CA2651907C - Systeme bipartite, procede et composition permettant l'expression constitutive et inductible de niveaux eleves de proteines etrangeres dans des plantes - Google Patents
Systeme bipartite, procede et composition permettant l'expression constitutive et inductible de niveaux eleves de proteines etrangeres dans des plantes Download PDFInfo
- Publication number
- CA2651907C CA2651907C CA2651907A CA2651907A CA2651907C CA 2651907 C CA2651907 C CA 2651907C CA 2651907 A CA2651907 A CA 2651907A CA 2651907 A CA2651907 A CA 2651907A CA 2651907 C CA2651907 C CA 2651907C
- Authority
- CA
- Canada
- Prior art keywords
- rna
- virus
- nucleic acid
- gfp
- construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
La présente invention concerne un système combiné de vecteur transgène/virus permettant l'expression de protéines hétérologues dans des plantes. Bien qu'elle soit exemplifiée relativement au phytovirus bipartite à ARN Cowpect mosaic virus (CPMV), il est possible d'utiliser avantageusement d'autres systèmes viraux bipartites selon le procédé, le système et la composition décrits en détail dans ce présent document.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2006/003548 WO2007135480A1 (fr) | 2006-05-22 | 2006-05-22 | Système bipartite, procédé et composition permettant l'expression constitutive et inductible de niveaux élevés de protéines étrangères dans des plantes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2651907A1 CA2651907A1 (fr) | 2007-11-29 |
| CA2651907C true CA2651907C (fr) | 2016-12-20 |
Family
ID=38068740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2651907A Expired - Fee Related CA2651907C (fr) | 2006-05-22 | 2006-05-22 | Systeme bipartite, procede et composition permettant l'expression constitutive et inductible de niveaux eleves de proteines etrangeres dans des plantes |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8519113B2 (fr) |
| EP (1) | EP2029755A1 (fr) |
| CA (1) | CA2651907C (fr) |
| WO (1) | WO2007135480A1 (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7683238B2 (en) | 2002-11-12 | 2010-03-23 | iBio, Inc. and Fraunhofer USA, Inc. | Production of pharmaceutically active proteins in sprouted seedlings |
| US7692063B2 (en) | 2002-11-12 | 2010-04-06 | Ibio, Inc. | Production of foreign nucleic acids and polypeptides in sprout systems |
| ES2531125T3 (es) | 2003-02-03 | 2015-03-10 | Ibio Inc | Sistema para la expresión de genes en plantas |
| EP1769068B1 (fr) | 2004-02-20 | 2014-12-31 | iBio, Inc. | Systemes et methodes d'expression clonale dans des plantes |
| WO2009076778A1 (fr) | 2007-11-27 | 2009-06-25 | Medicago Inc. | Particules pseudovirales (vlp) de la grippe recombinées produites dans des plantes transgéniques exprimant l'hémagglutinine |
| GB0800272D0 (en) * | 2008-01-08 | 2008-02-13 | Plant Bioscience Ltd | Protein expression systems |
| SG187500A1 (en) | 2008-01-21 | 2013-02-28 | Medicago Inc | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| IN2012DN00324A (fr) | 2009-06-15 | 2015-05-08 | Plant Bioscience Ltd | |
| HUE039100T2 (hu) | 2009-06-24 | 2018-12-28 | Medicago Inc | Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék |
| KR101773431B1 (ko) | 2009-09-22 | 2017-09-12 | 메디카고 인코포레이티드 | 식물-유래 vlp의 제조방법 |
| US8637653B2 (en) * | 2009-12-22 | 2014-01-28 | The United States Of America, As Represented By The Secretary Of Agriculture | Infectious plant viral vector and an artificial bipartite plant viral vector an infectious plant viral vector and an artificial bipartite plant viral vector |
| GB201002434D0 (en) | 2010-02-12 | 2010-03-31 | Plant Bioscience Ltd | Non-infectious RNA source |
| FI20100248A0 (fi) | 2010-06-11 | 2010-06-11 | Kristiina Maekinen | Menetelmä proteiinien tuottamiseksi |
| WO2012058762A1 (fr) | 2010-11-04 | 2012-05-10 | Medicago Inc. | Système d'expression végétale |
| CA2824155A1 (fr) | 2011-01-17 | 2012-07-26 | Philip Morris Products S.A. | Vecteurs pour l'expression d'acides amines dans des plantes |
| PT2665818T (pt) | 2011-01-17 | 2017-07-05 | Philip Morris Products Sa | Expressão de proteínas em plantas |
| TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
| GB201107468D0 (en) * | 2011-05-04 | 2011-06-15 | Plant Bioscience Ltd | Protein expression systems |
| JP6011759B2 (ja) * | 2011-09-16 | 2016-10-19 | 国立研究開発法人農業・食品産業技術総合研究機構 | サイレンシング抑制因子およびその取得方法 |
| NZ622731A (en) | 2011-09-30 | 2016-04-29 | Medicago Inc | Increasing virus-like particle yield in plants |
| US11390878B2 (en) | 2011-09-30 | 2022-07-19 | Medicago Inc. | Increasing protein yield in plants |
| ES2803508T3 (es) | 2013-03-28 | 2021-01-27 | Medicago Inc | Producción de partículas similares al virus de la gripe en plantas |
| US12467058B2 (en) | 2013-03-28 | 2025-11-11 | Aramis Biotechnologies Inc. | Influenza virus-like particle production in plants |
| CN103319609A (zh) * | 2013-07-05 | 2013-09-25 | 刘德虎 | 人碱性成纤维细胞生长因子融合基因及其应用 |
| CN103333256B (zh) * | 2013-07-05 | 2014-11-05 | 中国农业科学院生物技术研究所 | 人酸性成纤维细胞生长因子融合蛋白及其编码基因和应用 |
| RU2699982C2 (ru) * | 2014-01-10 | 2019-09-11 | Медикаго Инк. | Энхансерные элементы cpmv |
| US10563213B2 (en) | 2014-03-27 | 2020-02-18 | Medicago Inc. | Modified CPMV enhancer elements |
| RU2731295C2 (ru) | 2014-07-11 | 2020-09-01 | Медикаго Инк. | Модификация продуцирования белков в растениях |
| AU2016208999A1 (en) | 2015-01-23 | 2017-07-13 | Medicago Inc. | Rotavirus-like particle production in plants |
| CN110506118A (zh) * | 2017-02-02 | 2019-11-26 | 杜克大学 | 用于控制基因表达的组合物和方法 |
| GB201721600D0 (en) | 2017-12-21 | 2018-02-07 | Plant Bioscience Ltd | Metabolic engineering |
| GB201808617D0 (en) | 2018-05-25 | 2018-07-11 | Plant Bioscience Ltd | Scaffold modification |
| CN109576305B (zh) * | 2018-12-14 | 2020-10-23 | 中国农业科学院郑州果树研究所 | 一种携带增强型绿色荧光蛋白报告基因的南瓜花叶病毒重组载体及其构建方法 |
| WO2020181354A1 (fr) * | 2019-03-14 | 2020-09-17 | Mitsubishi Tanabe Pharma Corporation | Activateur d'expression de plante endogène |
| GB201908431D0 (en) | 2019-06-12 | 2019-07-24 | Plant Bioscience Ltd | Biosynthetic genes and polypeptides |
| GB201909104D0 (en) | 2019-06-25 | 2019-08-07 | Plant Bioscience Ltd | Transferase enzymes |
| CN111979262A (zh) * | 2020-06-08 | 2020-11-24 | 杭州师范大学 | 植物改造 |
| WO2022260849A1 (fr) | 2021-06-09 | 2022-12-15 | Nant Holdings Ip, Llc | Procédés et systèmes de production d'une protéine d'intérêt dans une plante |
| GB202209501D0 (en) | 2022-06-29 | 2022-08-10 | Plant Bioscience Ltd | Biosynthetic enzymes |
| KR20250082120A (ko) * | 2023-11-29 | 2025-06-09 | 서강대학교산학협력단 | 검은눈콩 모자이크 바이러스의 바이러스 유사 입자의 제조방법 및 이의 활용 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9712282D0 (en) * | 1997-06-12 | 1997-08-13 | Innes John Centre Innov Ltd | Epitope presentation system |
| DE10109354A1 (de) * | 2001-02-27 | 2002-09-05 | Icon Genetics Ag | Rekombinante virale Schaltersysteme |
| US7618815B2 (en) * | 2006-03-08 | 2009-11-17 | University Of Kentucky Research Foundation | Viral vectors useful in soybean and methods of use |
-
2006
- 2006-05-22 CA CA2651907A patent/CA2651907C/fr not_active Expired - Fee Related
- 2006-05-22 US US12/300,922 patent/US8519113B2/en not_active Expired - Fee Related
- 2006-05-22 WO PCT/IB2006/003548 patent/WO2007135480A1/fr not_active Ceased
- 2006-05-22 EP EP06831673A patent/EP2029755A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US8519113B2 (en) | 2013-08-27 |
| CA2651907A1 (fr) | 2007-11-29 |
| US20090181460A1 (en) | 2009-07-16 |
| EP2029755A1 (fr) | 2009-03-04 |
| WO2007135480A1 (fr) | 2007-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2651907C (fr) | Systeme bipartite, procede et composition permettant l'expression constitutive et inductible de niveaux eleves de proteines etrangeres dans des plantes | |
| RU2539793C2 (ru) | Системы экспрессии белка | |
| US6392121B1 (en) | Gemini virus vectors for gene expression in plants | |
| CA2571029C (fr) | Expression de proteines transitoires biologiquement sures dans des plantes | |
| JP5015012B2 (ja) | 植物におけるヘテロ‐オリゴマータンパク質の産生 | |
| Sempere et al. | Development of expression vectors based on pepino mosaic virus | |
| CA2554214A1 (fr) | Systeme d'expression de plante derivee d'un virus a arn a deux composants | |
| AU2015234595B2 (en) | Modified CPMV enhancer elements | |
| Castañón et al. | The effect of the promoter on expression of VP60 gene from rabbit hemorrhagic disease virus in potato plants | |
| US6849780B2 (en) | Plants resistant to cucumber mosaic virus strain V34 | |
| CN113661244A (zh) | 轮状病毒vp7融合蛋白和包含其的轮状病毒样颗粒 | |
| AU2015205805B2 (en) | CPMV enhancer elements | |
| CN107208072A (zh) | 在植物中产生轮状病毒样颗粒 | |
| Hefferon | Biopharmaceuticals in plants: toward the next century of medicine | |
| WO2024208914A1 (fr) | Système de vecteur trans-complémentaire pour expression génique hétérologue hautement efficace dans des plantes | |
| Tiwari et al. | High level expression of a functionally active cholera toxin B: rabies glycoprotein fusion protein in tobacco seeds | |
| Kim et al. | Expression of dengue virus EIII domain-coding gene in maize as an edible vaccine candidate | |
| CA2813986C (fr) | Molecules d'acide nucleique derivees d'un closterovirus et leurs utilisations | |
| WO2007138155A1 (fr) | Expression améliorée de protéines du vaccin contre la tuberculose dans des végétaux | |
| CN117003886A (zh) | 一种利用表达o157:h7抗原的转基因生菜研制的口服疫苗 | |
| Rattanaporn | Quantitative RNA Analysis and Roles of Viral RNA Silencing Suppressors in Transient Therapeutic Protein Production in Plant Tissues using a Viral Amplicon-Based System | |
| Liu | New viral vectors for the expression of antigens and antibodies in plants | |
| Hefferon | Novel approaches to protein expression using plant virus expression vectors | |
| Lee | Transformation of Brassica napus cv. Westar with the beet western yellows virus coat protein gene | |
| Gehringer | An investigation into the high level production of proteins in tobacco using transgenic plants or viral vectors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20210525 |